Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. (Q41141990)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Mehmet Demirci

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Reyhan Caliskan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hrisi Bahar Tokman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yusuf Erzin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Suat Saribas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Pelin Yuksel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ecehan Ozge Sevuk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ozge Yılmazli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ozer Akgul

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Fatma Kalayci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Huseyin Cakan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Barik Salih

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Kadir Bal

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Bekir Kocazeybek

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

Revista da Sociedade Brasileira de Medicina Tropical

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

278-284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26108005%20AND%20SRC:MED&resulttype=core&format=json

Current options for the treatment of Helicobacter pylori

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Characterization of monospecies biofilm formation by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Identification of Helicobacter pylori biofilms in human gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

High secondary resistance to quinolones in German Helicobacter pylori clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Clarithromycin resistance in Helicobacter pylori strains isolated from French children: prevalence of the different mutations and coexistence of clones harboring two different mutations in the same biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Quinolone resistance in Helicobacter pylori isolates in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015

Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0027-2015